IMMUNOMEDICS INC - NOTE 4.750% 2/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2020

Type / Class
Debt / NOTE 4.750% 2/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IMMUNOMEDICS INC - NOTE 4.750% 2/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2020 Q1 $0 $0 -$29,577,843 0
2019 Q4 $7,114,569 $29,576,040 +$12,040 415.92% 3
2019 Q3 $7,114,136 $18,787,803 +$1,803 264.98% 3
2019 Q2 $7,114,000 $19,617,000 275.7% 2
2019 Q1 $7,114,000 $27,105,000 +$34,282 381.05% 2
2018 Q4 $7,105,000 $20,382,000 -$54,581,976 286.71% 2
2018 Q3 $19,991,000 $82,966,000 414.25% 5
2018 Q2 $19,991,000 $93,488,000 +$14,587,219 467.11% 5
2018 Q1 $20,136,000 $59,455,000 -$1,747 295.0% 5
2017 Q4 $20,136,000 $65,473,000 +$13,978,083 325.17% 5
2017 Q3 $16,247,000 $45,945,000 -$147,564,126 282.6% 5
2017 Q2 $100,136,000 $183,257,000 +$9,182,201 183.18% 11
2017 Q1 $99,786,000 $140,444,000 +$6,199,033 140.51% 14
2016 Q4 $100,765,000 $100,121,000 +$662,754 99.15% 15
2016 Q3 $100,145,000 $87,566,000 +$987,923 86.74% 12
2016 Q2 $99,660,000 $69,257,000 +$4,736,156 69.56% 13
2016 Q1 $92,980,000 $64,189,000 +$57,028,000 68.86% 15